Compounded tirzepatide
boostAGErx vs NextMeds
Quick answer
NextMeds costs $129 a real month and boostAGErx costs $265 — a difference of $136 a month, or $1,632 a year. Both figures are computed from what each seller actually charges and how often, not from the price on its landing page.
Checked in . Both sellers are re-checked on the same schedule; a price either side changes after that date will not be reflected here until the next check.
boostAGErx or NextMeds?
NextMeds is the cheaper way to start, at $129 a month against $265 for boostAGErx, and since both charge one price whatever the dose, that gap of $136 holds all the way up. NextMeds names 50 states; boostAGErx does not say where it ships. Neither has an FDA warning letter on record.
What each one bills
| boostAGErx | NextMeds | |
|---|---|---|
| True monthly cost | $265 | $129 |
| Advertised as | $145 | $129 |
| Charged | every calendar month | every calendar month |
| Each charge | $265 | $129 |
| Price basis | the same at every dose | the same at every dose |
| Mandatory recurring fee | none found | none found |
| States it names | not published | 50 states |
| FDA warning letter | none on record | none on record |
Where they actually differ
- What they advertise is not what they bill. boostAGErx advertises $145 and bills $265.
How we know
Both figures were read on the seller’s own site and recomputed over a 30.4375-day calendar month from the charge and the billing period it covers. Neither is a seller’s own “/mo”. The full working for each — the charge, the period, the arithmetic and the date it was read — is on its own page: boostAGErx and NextMeds. The method is set out in how we verify.
To compare any two sellers in the index rather than these two, use the comparison tool.